Basement membrane alterations in psoriasis are accompanied by epidermal overexpression of MMP-2 and its inhibitor TIMP-2

Journal of Investigative Dermatology

Volumn 115, Issue 5, 2000, Pages 771-777

  Fleischmajer, Raul ^a   Kuroda, Kei ^a   Hazan, Rachel ^a   Gordon, Ronald E ^a   Lebwohl, Mark G ^a   Sapadin, Allen N ^a   Unda, Fernando ^b   Iehara, Noriyuki ^b   Yamada, Yoshihiko ^b  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Cell adhesion; MMP 2; Psoriasis; TIMP 2

Indexed keywords

GELATINASE A; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; CELL ADHESION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EPIDERMIS; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSORIASIS;

EID: 0033748378     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2000.00138.x     Document Type: Article

References (52)

1. Proteolytic remodeling of extracellular matrix
2. Tissue inhibitor of metalloproteinase-2 is expressed in the interstitial matrix in adult mouse organs and during embryonic development
3. Tissue inhibitors of matrix metalloproteinases in cancer
4. Suprabasal integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis
5. CD8+ T cells in psoriasis lesions preferentially use T-cell receptor Vb3 and/or Vb13.1 genes
6. Alanine scanning mutagenesis and functional analysis of the fibronectin-like collagen-binding domain from human 92KDa type IV collagenase
7. Tissue inhibitor of metalloproteinase-2 stimulates fibroblast proliferation via a cAMP-dependent mechanism
8. Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis
9. Mapping of domains in human laminin using monoclonal antibodies: Localization of the neurite promoting site
10. Distribution and isolation of four laminin variants; tissue restricted distribution of heterotrimers assembled from four different subunits
11. The 72-kDa and the 92-kDa gelatinases, but not their inhibitors TIMP-1 and TIMP-2, are expressed in early psoriatic lesions
12. Molecular basis of sun-induced premature skin ageing and retinoid antagonism
13. Immunochemistry of a keratinocyte-fibroblast co-culture model for reconstruction of human skin
14. Uninvolved skin from psoriatic patients develops signs of involved psoriatic skin after being grafted onto nude mice
15. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies
16. Determination of tissue inhibitor of metalloproteinase-2 (TIMP-2) in experimental animals using monoclonal antibodies against TIMP-2-specific oligopeptide
17. Human 72-kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteinases designated TIMP-2
18. Tissue inhibitors of metalloproteinases. Structure, regulation and biological functions
19. Structure and characterization of the human tissue inhibitor of metalloproteinase-2 (TIMP-2) gene
20. Cell growth-promoting activity of tissue inhibitor of metalloproteinase-2 (TIMP-2)
21. The genetics of psoriasis
22. Aberrant integrin expression during epidermal wound healing and in psoriatic epidermis
23. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice
24. Transforming growth factor-beta 1 localization in normal and psoriatic epidermal keratinocytes in situ
25. Involved and uninvolved skin from psoriatic subjects: Are they equally diseased?
26. Psoriasis
27. Evidence for an antigen-specific cellular immune response in skin of lesions patients with Psoriasis vulgaris
28. Behavior of laminin 1 and type IV collagen in uninvolved psoriasis skin. Immunohistochemical study using confocal laser scanning microscopy
29. Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue
30. Effect of tissue inhibitor of the matrix metalloproteinase-2 expression on the growth and spontaneous metastasis of a human melanoma cell line
31. Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteinases 1, 2, and 3 in fibroblasts
32. TIMP-2 a growth-stimulatory protein from SV40-transformed human fibroblasts
33. In situ hybridization analysis of chick embryos in whole mount and tissue sections
34. Differential expression of two basement membrane collagen genes COL4A6 and COL4A5, demonstrated by immunofluorescence staining using peptide-specific monoclonal antibodies
35. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzyme properties
36. Alterations of cell surfaces as a pathogenic factor in psoriasis
37. Transcriptional and post-transcriptional regulation of 72KDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparison with collagenase and tissue inhibitor of matrix metalloproteinase gene expression
38. Expression, topography, and function of integrin receptors are severely altered in keratinocytes from involved and uninvolved psoriatic skin
39. Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization
40. Transforming growth factor-β1 upregulates type IV collagenase expression in cultured human keratinocytes
41. Expression of metalloproteinase-2 and -9 during early human wound healing
42. Molecular heterogeneity of basal laminae: Isoforms of laminin and collagen IV at the neuromuscular junction and elsewhere
43. Membrane type matrix metalloproteinases (MT-MMPs) in tumor metastasis
44. A matrix metalloproteinase expressed on the surface of invasive tumour cells
45. Novel regulation of type IV collagenase (matrix metalloproteinase-9 and 2) activities by transforming growth factor-b1 in human prostate cancer cell lines
46. In situ hybridization analysis of cytokine, proto-oncogene and tumor gene expression in psoriasis
47. Tissue inhibitor of metalloproteinase-2 (TIMP-2) has erythroid-potentiating activity
48. Mechanism of cell surface activation of 72 KDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease
49. Differential expression of tissue inhibitor of metalloproteinase-2 by cutaneous squamous and basal cell carcinomas
50. The soluble catalytic domain of membrane type I matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates auto proteolytic activation
51. 72-kDa gelatinase (Gelatinase A): Structure, activation regulation and substrate specificity
52. The prevalence of psoriasis in the mongoloid race